menu search

DCGO / DocGo: Strong Showing Overall With Potential Fast Topline Growth

DocGo: Strong Showing Overall With Potential Fast Topline Growth
We saw our previous prediction of municipal contracts helping cushion DocGo's revenue (absent of the Covid test) work out for its full year of 2022. The technological advantage in operations and low debt burden combined with ample liquidity put the company on a strong footing for future growth. Read More
Posted: Mar 15 2023, 17:34
Author Name: Seeking Alpha
Views: 110777

DCGO News  

Why DocGo Stock Plummeted by 7% on Monday

By The Motley Fool
September 18, 2023

Why DocGo Stock Plummeted by 7% on Monday

Its CEO resigned abruptly. His official bio stated falsely that he earned a master's degree in artificial intelligence (AI). more_horizontal

DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?

By Zacks Investment Research
September 15, 2023

DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?

DocGo Inc. (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the s more_horizontal

DocGo: Preventing Onboarding Problem From Turning Into A Crisis (Rating Downgrade)

By Seeking Alpha
September 11, 2023

DocGo: Preventing Onboarding Problem From Turning Into A Crisis (Rating Downgrade)

DocGo was rewarded a no-bid contract by the NYC to provide medical care for the migrants, but this large contract is facing the risk of being revoked more_horizontal

Why Shares of DocGo Are Slumping Wednesday

By The Motley Fool
September 6, 2023

Why Shares of DocGo Are Slumping Wednesday

DocGo improved revenue in the second quarter. The company has added major contracts this year with EmblemHealth and Carnival Cruise Lines. more_horizontal

DocGo Inc. (DCGO) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 7, 2023

DocGo Inc. (DCGO) Q2 2023 Earnings Call Transcript

DocGo Inc. (NASDAQ:DCGO ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Corporate Participants Mike Cole - Director-Investor Relations An more_horizontal

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 7, 2023

DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates

DocGo Inc. (DCGO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.07 p more_horizontal

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

By Zacks Investment Research
June 22, 2023

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for th more_horizontal

DocGo's growth story keeps building, analysts say after mixed 1Q results

By Proactive Investors
May 12, 2023

DocGo's growth story keeps building, analysts say after mixed 1Q results

DocGo delivered what analysts at Canaccord called “mixed” results, but that was enough for the firm to reiterate its Buy rating and $13 price targ more_horizontal


Search within

Pages Search Results: